Literature DB >> 21282489

General principles of antimicrobial therapy.

Surbhi Leekha1, Christine L Terrell, Randall S Edson.   

Abstract

Antimicrobial agents are some of the most widely, and often injudiciously, used therapeutic drugs worldwide. Important considerations when prescribing antimicrobial therapy include obtaining an accurate diagnosis of infection; understanding the difference between empiric and definitive therapy; identifying opportunities to switch to narrow-spectrum, cost-effective oral agents for the shortest duration necessary; understanding drug characteristics that are peculiar to antimicrobial agents (such as pharmacodynamics and efficacy at the site of infection); accounting for host characteristics that influence antimicrobial activity; and in turn, recognizing the adverse effects of antimicrobial agents on the host. It is also important to understand the importance of antimicrobial stewardship, to know when to consult infectious disease specialists for guidance, and to be able to identify situations when antimicrobial therapy is not needed. By following these general principles, all practicing physicians should be able to use antimicrobial agents in a responsible manner that benefits both the individual patient and the community.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21282489      PMCID: PMC3031442          DOI: 10.4065/mcp.2010.0639

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  54 in total

1.  Penicillin skin testing: a way to optimize antibiotic utilization.

Authors:  A D Harris; L Sauberman; L Kabbash; D K Greineder; M H Samore
Journal:  Am J Med       Date:  1999-08       Impact factor: 4.965

2.  Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship.

Authors:  Timothy H Dellit; Robert C Owens; John E McGowan; Dale N Gerding; Robert A Weinstein; John P Burke; W Charles Huskins; David L Paterson; Neil O Fishman; Christopher F Carpenter; P J Brennan; Marianne Billeter; Thomas M Hooton
Journal:  Clin Infect Dis       Date:  2006-12-13       Impact factor: 9.079

3.  Intravenous immunoglobulin therapy for streptococcal toxic shock syndrome--a comparative observational study. The Canadian Streptococcal Study Group.

Authors:  R Kaul; A McGeer; A Norrby-Teglund; M Kotb; B Schwartz; K O'Rourke; J Talbot; D E Low
Journal:  Clin Infect Dis       Date:  1999-04       Impact factor: 9.079

4.  Emergence of fluoroquinolones as the predominant risk factor for Clostridium difficile-associated diarrhea: a cohort study during an epidemic in Quebec.

Authors:  Jacques Pépin; Nathalie Saheb; Marie-Andrée Coulombe; Marie-Eve Alary; Marie-Pier Corriveau; Simon Authier; Michel Leblanc; Geneviève Rivard; Mathieu Bettez; Valérie Primeau; Martin Nguyen; Claude-Emilie Jacob; Luc Lanthier
Journal:  Clin Infect Dis       Date:  2005-09-20       Impact factor: 9.079

5.  Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study.

Authors:  Krista S Crider; Mario A Cleves; Jennita Reefhuis; Robert J Berry; Charlotte A Hobbs; Dale J Hu
Journal:  Arch Pediatr Adolesc Med       Date:  2009-11

Review 6.  The rational clinical examination. Is this patient allergic to penicillin? An evidence-based analysis of the likelihood of penicillin allergy.

Authors:  A R Salkind; P G Cuddy; J W Foxworth
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

7.  Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients.

Authors:  M H Kollef; G Sherman; S Ward; V J Fraser
Journal:  Chest       Date:  1999-02       Impact factor: 9.410

8.  Emergency department visits for antibiotic-associated adverse events.

Authors:  Nadine Shehab; Priti R Patel; Arjun Srinivasan; Daniel S Budnitz
Journal:  Clin Infect Dis       Date:  2008-09-15       Impact factor: 9.079

9.  High sensitivity of human leukocyte antigen-b*5701 as a marker for immunologically confirmed abacavir hypersensitivity in white and black patients.

Authors:  Michael Saag; Rukmini Balu; Elizabeth Phillips; Philip Brachman; Claudia Martorell; William Burman; Britt Stancil; Michael Mosteller; Cindy Brothers; Paul Wannamaker; Arlene Hughes; Denise Sutherland-Phillips; Simon Mallal; Mark Shaefer
Journal:  Clin Infect Dis       Date:  2008-04-01       Impact factor: 9.079

10.  Cost analysis of switching from i.v. vancomycin to p.o. linezolid for the management of methicillin-resistant Staphylococcus species.

Authors:  Marianne McCollum; David C Rhew; Stephen Parodi
Journal:  Clin Ther       Date:  2003-12       Impact factor: 3.393

View more
  146 in total

Review 1.  The Use of Antibiograms in Orthopedic Surgery.

Authors:  Scott R Nodzo; Nicholas B Frisch
Journal:  Curr Rev Musculoskelet Med       Date:  2018-09

Review 2.  Ceftaroline fosamil: a review of its use in the treatment of complicated skin and soft tissue infections and community-acquired pneumonia.

Authors:  James E Frampton
Journal:  Drugs       Date:  2013-07       Impact factor: 9.546

3.  Macrophage-targeted drugamers with enzyme-cleavable linkers deliver high intracellular drug dosing and sustained drug pharmacokinetics against alveolar pulmonary infections.

Authors:  Fang-Yi Su; Selvi Srinivasan; Brian Lee; Jasmin Chen; Anthony J Convertine; Timothy Eoin West; Daniel M Ratner; Shawn J Skerrett; Patrick S Stayton
Journal:  J Control Release       Date:  2018-08-09       Impact factor: 9.776

Review 4.  Methodology in improving antibiotic implementation policies.

Authors:  Onur Özgenç
Journal:  World J Methodol       Date:  2016-06-26

5.  In Vitro Fractional Inhibitory Concentration (FIC) Study of Cefixime and Azithromycin Fixed Dose Combination (FDC) Against Respiratory Clinical Isolates.

Authors:  Saiprasad Vilas Patil; Anoop Laxminarayan Hajare; Manjusha Patankar; K Krishnaprasad
Journal:  J Clin Diagn Res       Date:  2015-02-01

6.  Antibiotics in Development for the Treatment of Resistant Bacterial Disease.

Authors:  Ryan Kidd; Scot Walker
Journal:  Hosp Pharm       Date:  2017-11-07

7.  Comparative-effectiveness of ceftaroline and daptomycin as first-line MRSA therapy for patients with sepsis admitted to hospitals in the United States Veterans Health Care System.

Authors:  Marilyn L Mootz; Rachel S Britt; Allison A Mootz; Grace C Lee; Kelly R Reveles; Kirk E Evoy; Chengwen Teng; Christopher R Frei
Journal:  Hosp Pract (1995)       Date:  2019-10-14

8.  Relative potency of proton-pump inhibitors, Helicobacter pylori therapy cure rates, and meaning of double-dose PPI.

Authors:  David Y Graham; Hong Lu; Maria Pina Dore
Journal:  Helicobacter       Date:  2018-11-15       Impact factor: 5.753

9.  Houston Consensus Conference on Testing for Helicobacter pylori Infection in the United States.

Authors:  Hashem B El-Serag; John Y Kao; Fasiha Kanwal; Mark Gilger; Frank LoVecchio; Steven F Moss; Sheila E Crowe; Adam Elfant; Thomas Haas; Ronald J Hapke; David Y Graham
Journal:  Clin Gastroenterol Hepatol       Date:  2018-03-17       Impact factor: 11.382

Review 10.  Inducing stable reversion to achieve cancer control.

Authors:  Scott Powers; Robert E Pollack
Journal:  Nat Rev Cancer       Date:  2016-04       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.